Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-03 Sale |
2022-10-03 8:27 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
6,682 | $148.5 | $992,277 | 1,614 (Indirect Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 5:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $67.38 | $3,504,001 | 38,062 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-07 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
342 | $128.87 | 22,176 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
551 | $123.86 | 22,176 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
2,125 | $0 | 22,176 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:18 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
10,500 | $0 | 22,176 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
492 | $115.55 | 6,281 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 6,281 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
492 | $83.38 | 23,023 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 23,023 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:49 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
15,000 | $0 | 23,023 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
480 | $90.14 | 5,654 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 5,654 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $9.29 | 38,062 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:19 pm |
N/A 2027-01-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
52,000 | $0 | 38,062 (Direct) |
View |